Products for Research Use Only
RegisterLogin

Rimteravimab

CAT: 0804-HY-P99947-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99947-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2[1].
CAS Number
2540797-21-3
Product Name Alternative
XVR011
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rimteravimab.html
Purity
99
Solubility
10 mM in DMSO
Smiles
[Rimteravimab]
Molecular Weight
(79.1 kDa)
References & Citations
[1]Bert Schepens, et al. An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Sci Transl Med. 2021 Nov 24;13 (621) :eabi7826. |[2]Schepens B, et al., An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models. Sci Transl Med. 2021 Nov 24;13 (621) :eabi7826.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T77182-01Rimteravimab
GTR18338013-01Rimteravimab Antibody
WA3458Research Grade Rimteravimab
E55B1147Rimteravimab (Reference antibody)
ICH5823-10mgRimteravimab Biosimilar - Research Grade
GTR18697269-01Rimteravimab Chimeric Monoclonal Antibody
GTR18780345-01(Rimteravimab) Biosimilar Reference Antibody
PX-TA1804-01Rimteravimab Biosimilar - Anti-Spike RBD mAb - Research Grade
A135572Rimteravimab Biosimilar (Monoclonal, [VH-h-CH2-CH3]-dimer)
RA0662-01Rimteravimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)

Popular Products